A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age
Clinical trial NCT06113198 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06113198
- Sponsor
- GlaxoSmithKline
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-10
- Primary completion
- 2026-09-07
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.